BNP Paribas Financial Markets
ETNB

BNP Paribas Financial Markets’s 89bio ETNB Stock Holding History

BNP Paribas Financial Markets’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,132
Closed -$369K – 5795
2025
Q3 		$369K Buy
25,132
+6,590
+36% +$67.2K ﹤0.01% 3720
2025
Q2 		$182K Sell
18,542
-50,732
-73% -$420K ﹤0.01% 3802
2025
Q1 		$504K Sell
69,274
-282,057
-80% -$2.47M ﹤0.01% 3182
2024
Q4 		$2.75M Buy
+351,331
New +$2.89M ﹤0.01% 2180
2022
Q4 		– Sell
-187
Closed -$1.08K – 4224
2022
Q3 		$1.08K Buy
+187
New +$822 ﹤0.01% 4418

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BNP Paribas Financial Markets's ETNB Position: Q4 2025 in Review

BNP Paribas Financial Markets sold out of 89bio (ETNB) in Q4 2025, closing a stake of 25,132 shares — an estimated $369K sold.

BNP Paribas Financial Markets first reported a position in ETNB in Q3 2022 and held it in 5 quarters. The position peaked at $2.75M in Q4 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • BNP Paribas Financial Markets reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 25,132 89bio shares in Q4 2025, an estimated $369K.
  • BNP Paribas Financial Markets first reported a position in 89bio in Q3 2022 and held it in 5 quarters.
  • BNP Paribas Financial Markets's 89bio position peaked at $2.75M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.